Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

10-10-2018 | Mental health | Editorial | Article

Why depression and anxiety matter in patients with inflammatory arthritis

Advisory Board member Susan Bartlett discusses the prevalence of mental health comorbidities in patients with inflammatory arthritis, and their impact on disease symptoms and quality of life.

11-10-2018 | Gout | Highlight | News

Allopurinol does not increase CKD risk in patients with gout

Allopurinol, given at a starting dose of at least 300 mg/day, does not increase the risk for chronic kidney disease stage 3 or higher, and may in fact reduce it, in patients with newly diagnosed gout, study data show.

27-09-2018 | Fibromyalgia | Editorial | Article

Treatment and outcomes of pediatric fibromyalgia: More than resolving pain

David Sherry discusses various pharmacologic and non-pharmacologic treatments for management of pediatric fibromyalgia, and outlines the impact of an interdisciplinary approach on physical function, mental health and pain outcomes in these patients.

Latest from across the site

15-10-2018 | Juvenile idiopathic arthritis | News

Response to canakinumab sustained for up to 5 years in children with sJIA

Response to canakinumab therapy is sustained or even improved for up to 5 years in children with systemic juvenile idiopathic arthritis, with no new safety signals, according to the results of a long-term extension study published in the Annals of the Rheumatic Diseases.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2018-213150

12-10-2018 | Gout | News

Substantial role for diet in gout refuted

A meta-analysis published in The BMJ suggests that diet only explains a small proportion of variation in serum uric acid levels, with genetic variation making a much larger contribution to hyperuricemia risk.

Source:

BMJ 2018; 363: k3951, k4140

11-10-2018 | Gout | Highlight | News

Allopurinol does not increase CKD risk in patients with gout

Allopurinol, given at a starting dose of at least 300 mg/day, does not increase the risk for chronic kidney disease stage 3 or higher, and may in fact reduce it, in patients with newly diagnosed gout, study data show.

Source:

JAMA Intern Med 2018; doi:10.1001/jamainternmed.2018.4463

10-10-2018 | Systemic lupus erythematosus | News

Musculoskeletal inflammation in SLE not reliably identified with existing clinical instruments

Existing classification systems for musculoskeletal symptoms in people with systemic lupus erythematosus fail to identify inflammation in a large proportion of those with synovitis, suggest findings reported in Rheumatology.

Source:

Rheumatology 2018; doi:10.1093/rheumatology/key277

10-10-2018 | Mental health | Editorial | Article

Why depression and anxiety matter in patients with inflammatory arthritis

Advisory Board member Susan Bartlett discusses the prevalence of mental health comorbidities in patients with inflammatory arthritis, and their impact on disease symptoms and quality of life.

Author:
Susan Bartlett

08-10-2018 | Vitamin D | News

No benefit of vitamin D supplementation for musculoskeletal health

The use of vitamin D supplements for maintaining or improving musculoskeletal health is not warranted, suggest the findings of an updated systematic review and meta-analysis.

Source:

Lancet Diabetes Endocrinol 2018; doi:10.1016/S2213-8587(18)30265-1
Lancet Diabetes Endocrinol 2018; doi:10.1016/S2213-8587(18)30269-9

Meet our Editorial Board

New Content Item Meet our Advisory Board

image credits